Association of c-Myc and Immune Cell Infiltration in Small Cell Lung Carcinoma
Frontiers in Bioscience-Landmark · 2026
DOI: 10.31083/fbl52899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Peiyan Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Oncology Research Lab, Jilin Cancer Hospital, 130000 Changchun, Jilin, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Proto-Oncogene Proteins c-myc, Small Cell Lung Carcinoma, Lymphocytes, Tumor-Infiltrating. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Provincial Department of Science and Technology, China Association for Science and Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background:Small cell lung carcinoma (SCLC) is a highly aggressive, rapidly proliferating malignancy largely corresponding to immune-cold tumor type. The role of the key oncogene c-Myc in regulating the complex immune microenvironment of SCLC remains unknown.Methods:Immunohistochemistry and multiplex immunofluorescence techniques were used to analyze c-Myc expression and immune cell infiltration. c-Myc and β-catenin expression were analyzed using western blotting. Flow cytometry was used to quantify the expression of immunosuppressive ligands—including programmed death ligand 1 (PD-L1), CD47, CD155, and human leukocyte antigen-E (HLA-E)—and characterize the function of T cells and macrophages. Cytokine levels were evaluated using enzyme-linked immunosorbent assays.Results:c-Myc expression in high tumor-infiltrating lymphocyte infiltration (TILhigh) tumor exceeded that in TILlow tumors (n = 24) and was positively correlated with CD163+ macrophage infiltration (p = 0.0180). Immunosuppressive ligands were universally expressed on SCLC cells. 10058-F4—a c-Myc inhibitor—substantially downregulated the expression of PD-L1, CD47, and CD155 and upregulated HLA-E expression. In the coculture system, the inhibition of c-Myc in SCLC cells significantly upregulated interferon-gamma production in Jurkat cells, inhibited macrophage phagocytosis, and decreased cytokine concentrations in the supernatant. Further mechanistic studies revealed that c-Myc inhibition modulated the Notch signaling pathway and reduced the expression of E-cadherin, vascular endothelial (VE)-cadherin, and β-catenin. A β-catenin agonist improved the regulatory effect of 10058-F4 on the immunosuppressive ligands in SCLC cells.Conclusions:c-Myc expression in SCLC is associated with immune infiltration and may regulate the expression of immune-related ligands on SCLC cells via WNT/β-catenin signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Oncology Research Lab, Jilin Cancer Hospital, 130000 Changchun, Jilin, China.
- Jilin Provincial Key Laboratory of Molecular Diagnostics for Malignant Tumor, Jilin Cancer Hospital, 130000 Changchun, Jilin, China.
- Biobank, Jilin Cancer Hospital, 130000 Changchun, Jilin, China.
Förderung
- Jilin Provincial Department of Science and Technology
- China Association for Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Zhao, P., Li, H., Wang, X., Di, N., Liu, Y., Tian, L., Zhong, R., Liang, C., & Liu, H. (2026). Association of c-Myc and Immune Cell Infiltration in Small Cell Lung Carcinoma. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl52899
Vancouver
Zhao P, Li H, Wang X, Di N, Liu Y, Tian L, et al. Association of c-Myc and Immune Cell Infiltration in Small Cell Lung Carcinoma. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl52899
BibTeX
@article{Zhao2026,
author = {Zhao, Peiyan and Li, Hui and Wang, Xinyue and Di, Na and Liu, Yan and Tian, Lin and Zhong, Rui and Liang, Changlin and Liu, Haifeng},
title = {Association of c-Myc and Immune Cell Infiltration in Small Cell Lung Carcinoma},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
doi = {10.31083/fbl52899}
}
EUVIMED